HELIX ACQUISITION CORP. HLXA 深 沪
等待开盘 01-12 09:30:00 美东时间
13.25
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 13.25
- 总市值 1.96亿
- 52周最高 15.19
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 8.90
- 委 比 0.00%
- 总股本 1480.50万
- 历史最高 15.19
- 量 比 0
- 振 幅 0.00%
- 历史最低 8.90
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Medicus Pharma Ltd. Studies Demonstrate Long-Acting Therapeutic Approach with Stable Bone Turnover in Women
Medicus Pharma announced the acceptance of its abstract on Teverelix, a long-acting GnRH antagonist, for presentation at the 2026 AACE Annual Meeting. The abstract highlights Phase 1 study results demonstrating rapid hormone suppression, stable bone markers, and favorable safety profiles in healthy women. These findings support potential use in endometriosis, with plans for a Phase 2 study in the UAE. Additionally, SkinJect™, a microneedle delive...
今天 12:30
Helix Collaborates With GSK To Provide Access To Its Phenotyped GenoSphere Cohorts
Helix, the leading enterprise genomics company, today announced a multi-year strategic collaboration with GSK, the global biopharma company. This agreement provides GSK access to Helix's continuously growing, deeply
01-07 22:07
EUDA Health Said It Will Launch EUDA Helixé 2.0 In January 2026, Marking An Upgrade Of Its Youthful Vitality And Longevity Supplement
Strengthened Formula and Ingredient OptimizationEUDA Helixé 2.0 features a 20% increase in New Zealand sourced deer placenta powder, with dosage enhanced from 100 mg to 120 mg, reinforcing the supplement's positioning as
2025-12-29 20:03
Helix Resources Director Adjusts Option Holdings as Lapsed Securities Disclosed
Helix Resources Limited ( ($AU:HLX) ) just unveiled an announcement. Helix Reso...
2025-12-22 11:17
Altria (MO) Wins FDA Approval for on! PLUS, Expands in Oral Nicotine Market
The U.S. Food and Drug Administration has authorized six on! PLUS nicotine pouc...
2025-12-21 18:40
Helix Energy Solutions Group CEO Owen Kratz To Retire
Helix Energy Solutions Group, Inc. (NYSE:HLX) ("Helix" or the "Company") today announced that Owen Kratz, President and Chief Executive Officer ("CEO") and member of the Helix Board of Directors (the "Board"), has
2025-12-18 07:01
KellyOCG + Sevenstep Named No. 1 Provider of Total Workforce Solutions
KellyOCG® + Sevenstep was named the No. 1 provider in HRO Today’s 2025 Baker’s Dozen Customer Satisfaction Ratings for Total Workforce Solutions. The ranking, based on customer feedback from nearly 500 companies, recognizes KellyOCG + Sevenstep for its superior service quality, breadth of offerings, and innovative technology. The company also topped the "Quality of Service" and "Breadth of Service" categories. KellyOCG + Sevenstep integrates MSP,...
2025-12-17 15:06
BioCardia Announces Election of New Board Director, Marvin Slosman and Completion of Term for Outgoing Director, Dr. Richard Krasno
BioCardia announced the election of Mr. Marvin Slosman to its Board of Directors and the departure of Dr. Richard Krasno. Mr. Slosman, with extensive experience in interventional cardiology and medical technology, is expected to contribute significantly to the company's growth and innovation. Dr. Krasno, who served since 2016, was instrumental in advancing key initiatives, including FDA approvals and expanding therapeutic areas. The company expre...
2025-12-03 13:00
BBOT Reports Third Quarter 2025 Financial Results and Update on Corporate Progress
BBOT, a clinical-stage biopharma company focused on RAS and PI3Kα pathway malignancies, reported Q3 2025 financials with $468.3M cash runway, advancing three Phase 1 KRAS and PI3Kα inhibitors.近的数据读出预计2026年，任命新任CFO。季度R&D费用达到3510万美元，管理费用为1410万美元，总净亏损4470万美元。
2025-11-12 21:05
